PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Institute of Immunity & Transplantation, University College London, Royal Free Campus, London NW3 2PF, UK. Electronic address: matthew.murray@ucl.ac.uk.\', \'Institute of Immunity & Transplantation, University College London, Royal Free Campus, London NW3 2PF, UK.\', \'Department of Infectious Diseases, Royal Free Hospital London NHS Foundation Trust, London NW3 2PF, UK.\', \'School of Life Sciences, University of Sussex, Brighton, UK.\', \'Health Services Laboratories LLP, London, UK.\', \'Institute of Immunity & Transplantation, University College London, Royal Free Campus, London NW3 2PF, UK. Electronic address: matthew.reeves@ucl.ac.uk.\']
?:citedBy
  • -1
?:creator
?:doi
  • S0163-4453(21)00127-410.1016/j.jinf.2021.03.010
?:doi
?:hasPublicationType
?:journal
  • The Journal of infection
is ?:pmid of
?:pmid
?:pmid
  • 33753152
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
?:title
  • Validation of a commercially available indirect assay for SARS-CoV-2 neutralising antibodies using a pseudotyped virus assay.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all